Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Magnesium oxide
Drug ID BADD_D02442
Description Magnesium oxide is an inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.
Indications and Usage Indicated for over-the-counter use as a supplement for cardiovascular and neuromuscular health, and as an antacid for relief of acid indigestion and upset stomach.
Marketing Status approved
ATC Code A02AA02; A06AD02; A12CC10
DrugBank ID DB01377
KEGG ID D01167
MeSH ID D008277
PubChem ID 14792
TTD Drug ID Not Available
NDC Product Code 12784-437; 50917-857; 54738-973; 69367-298; 0603-0213; 54738-974; 71610-172; 71610-182; 0603-0209; 83335-001; 10135-721; 24689-132; 50917-887; 58657-120; 63629-1126; 50917-837; 63629-2217; 63629-9420; 68210-4171; 71335-1960; 50917-867; 50917-877; 55570-280
UNII 3A3U0GI71G
Synonyms Magnesium Oxide | Oxide, Magnesium | Magnesia
Chemical Information
Molecular Formula MgO
CAS Registry Number 1309-48-4
SMILES O=[Mg]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.0020.000274%
Abdominal pain upper07.01.05.0030.000182%
Altered state of consciousness17.02.04.001; 19.07.01.0030.000274%-
Anaemia01.03.02.0010.000638%
Anaphylactic reaction10.01.07.001; 24.06.03.0060.000401%
Arrhythmia02.03.02.0010.000182%-
Asthenia08.01.01.0010.000274%-
Breast cancer16.10.01.001; 21.05.01.0030.000182%-
Cerebral infarction17.08.01.004; 24.04.06.0020.000274%-
Chills08.01.09.001; 15.05.03.0160.000182%
Colitis ischaemic07.08.01.004; 24.04.08.0120.000182%-
Coma17.02.09.0010.000274%-
Condition aggravated08.01.03.0040.000274%-
Constipation07.02.02.0010.000638%
Depressed level of consciousness17.02.04.0020.000365%
Depression19.15.01.0010.000182%
Diabetes mellitus inadequate control05.06.01.004; 14.06.01.0040.000182%-
Diarrhoea07.02.01.0010.001368%
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.0070.000675%
Drug eruption08.01.06.015; 10.01.01.005; 23.03.05.0010.000182%-
Drug interaction08.06.03.0010.000274%-
Dry mouth07.06.01.0020.000274%
Dyskinesia17.01.02.0060.000182%
Dysphagia07.01.06.0030.000365%
Erythema23.03.06.0010.000274%-
Gastrointestinal disorder07.11.01.0010.000182%-
Haematochezia07.12.02.003; 24.07.02.0120.000274%-
Haemorrhage subcutaneous23.06.07.002; 24.07.06.0100.000182%-
Hepatic failure09.01.03.0020.000182%
Hepatic function abnormal09.01.02.0010.000675%-
The 1th Page    1 2 3    Next   Last    Total 3 Pages